Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BioKangtai(300601) the Revenue is 641.89 M (-14.05%), Miss estimate;the EBIT is 70.11 M (+26.01%), Miss estimate;the EPS is 0.02 (+100%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.64B14.05%
0.76B1.86%
-0.12B15.91%
EBITMiss expectations
0.07B26.01%
0.07B26.23%
-0.00B0.22%
EPSMiss expectations
0.02100.00%
0.0478378.30%
-0.0278278.30%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf